{"id":6778,"date":"2026-04-20T20:29:52","date_gmt":"2026-04-20T17:29:52","guid":{"rendered":"https:\/\/dbsnewsmedia.com\/?p=6778"},"modified":"2026-04-20T20:29:52","modified_gmt":"2026-04-20T17:29:52","slug":"pankreas-kanserine-karsi-yeni-umut-kapisi","status":"publish","type":"post","link":"https:\/\/dbsnewsmedia.com\/?p=6778","title":{"rendered":"Pankreas Kanserine Kar\u015f\u0131 Yeni Umut Kap\u0131s\u0131"},"content":{"rendered":"\n

20.04.2026 20:30<\/p>\n\n\n\n

ABD\u2019de geli\u015ftirilen yeni bir ila\u00e7, pankreas kanseri tedavisinde dikkat \u00e7ekici sonu\u00e7lar verdi. Elraglusib adl\u0131 deneysel ilac\u0131n kemoterapiyle birlikte kullan\u0131lmas\u0131, ileri evre pankreas kanseri hastalar\u0131nda hem ya\u015fam s\u00fcresini uzatt\u0131 hem de \u00f6l\u00fcm riskini belirgin bi\u00e7imde d\u00fc\u015f\u00fcrd\u00fc. Uzmanlara g\u00f6re bu sonu\u00e7lar, tedavisi en zor kanser t\u00fcrlerinden birinde yeni bir umut kap\u0131s\u0131 aralayabilir.<\/p>\n\n\n\n

ABD\u2019de geli\u015ftirilen yeni bir ila\u00e7, pankreas kanseri tedavisinde dikkat \u00e7ekici sonu\u00e7lar verdi. Elraglusib adl\u0131 deneysel ilac\u0131n kemoterapiyle birlikte kullan\u0131lmas\u0131, ileri evre pankreas kanseri hastalar\u0131nda hem ya\u015fam s\u00fcresini uzatt\u0131 hem de \u00f6l\u00fcm riskini belirgin bi\u00e7imde d\u00fc\u015f\u00fcrd\u00fc. Uzmanlara g\u00f6re bu sonu\u00e7lar, tedavisi en zor kanser t\u00fcrlerinden birinde yeni bir umut kap\u0131s\u0131 aralayabilir.<\/p>\n\n\n\n

Pankreas kanseriyle ilgili yeni bir \u00e7al\u0131\u015fma, t\u0131p d\u00fcnyas\u0131nda dikkat \u00e7ekici bir umut yaratt\u0131. ABD\u2019de geli\u015ftirilen elraglusib adl\u0131 deneysel ila\u00e7, standart kemoterapiyle birlikte kullan\u0131ld\u0131\u011f\u0131nda ileri evre pankreas kanseri hastalar\u0131nda ya\u015fam s\u00fcresini uzatt\u0131 ve \u00f6l\u00fcm riskini anlaml\u0131 bi\u00e7imde d\u00fc\u015f\u00fcrd\u00fc. Sonu\u00e7lar, pankreas kanseri gibi tedavisi en zor kanser t\u00fcrlerinden birinde yeni bir d\u00f6nemin kap\u0131s\u0131n\u0131 aralayabilecek nitelikte g\u00f6r\u00fcl\u00fcyor.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

\u00c7al\u0131\u015fma, metastatik yani ba\u015fka b\u00f6lgelere yay\u0131lm\u0131\u015f pankreas kanseri bulunan 233 hasta \u00fczerinde y\u00fcr\u00fct\u00fcld\u00fc. Hastalar\u0131n bir b\u00f6l\u00fcm\u00fc yaln\u0131zca standart kemoterapi al\u0131rken, di\u011fer gruba kemoterapiye ek olarak elraglusib verildi. Sonu\u00e7lara g\u00f6re yeni ilac\u0131 alan hastalar ortalama 10,1 ay ya\u015farken, yaln\u0131zca kemoterapi alan grupta bu s\u00fcre 7,2 ayda kald\u0131. Ara\u015ft\u0131rmac\u0131lar ayr\u0131ca toplam \u00f6l\u00fcm riskinin y\u00fczde 38 azald\u0131\u011f\u0131n\u0131 bildirdi.<\/p>\n\n\n\n

Ya\u015fam oran\u0131 artt\u0131<\/strong><\/h2>\n\n\n\n

\u00c7al\u0131\u015fman\u0131n en dikkat \u00e7ekici bulgular\u0131ndan biri, 1 y\u0131ll\u0131k ya\u015fam oranlar\u0131nda g\u00f6r\u00fcld\u00fc. Elraglusib verilen hastalar\u0131n yakla\u015f\u0131k y\u00fczde 44\u2019\u00fc 1 y\u0131l sonra hayattayd\u0131. Sadece kemoterapi alan grupta ise bu oran y\u00fczde 22\u2019de kald\u0131.<\/p>\n\n\n\n

2 y\u0131l sonunda da yeni ila\u00e7 verilen grupta hastalar\u0131n yakla\u015f\u0131k y\u00fczde 13\u2019\u00fc ya\u015fam\u0131n\u0131 s\u00fcrd\u00fcr\u00fcrken, yaln\u0131zca kemoterapi alan grupta bu s\u00fcreye ula\u015fan hasta olmad\u0131. Ara\u015ft\u0131rman\u0131n yazarlar\u0131, bu sonu\u00e7lar\u0131n \u00f6zellikle pankreas kanseri gibi \u00e7ok agresif seyreden bir hastal\u0131kta \u00f6nemli oldu\u011funu vurguluyor.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Yine de bunun hen\u00fcz son ad\u0131m olmad\u0131\u011f\u0131n\u0131n alt\u0131 \u00e7iziliyor. \u00c7\u00fcnk\u00fc \u00e7al\u0131\u015fma faz 2 d\u00fczeyinde; yani daha geni\u015f hasta gruplar\u0131nda yap\u0131lacak faz 3 denemeleriyle sonu\u00e7lar\u0131n do\u011frulanmas\u0131 gerekiyor. Buna ra\u011fmen elde edilen verilerin temkinli bir iyimserlik yaratt\u0131\u011f\u0131 belirtiliyor.<\/p>\n\n\n\n

Beyaz kan h\u00fccrelerinde d\u00fc\u015f\u00fc\u015f <\/strong><\/h2>\n\n\n\n

Yeni ilac\u0131n yan etkileri tamamen ortadan kalkm\u0131\u015f de\u011fil. Ara\u015ft\u0131rmada, beyaz kan h\u00fccrelerinde d\u00fc\u015f\u00fc\u015f, halsizlik ve ge\u00e7ici g\u00f6rme de\u011fi\u015fikliklerinin elraglusib kullanan grupta biraz daha s\u0131k g\u00f6r\u00fcld\u00fc\u011f\u00fc belirtildi. Ancak ara\u015ft\u0131rmac\u0131lara g\u00f6re bu yan etkiler geri d\u00f6nd\u00fcr\u00fclebilir nitelikte ve ilac\u0131n genel g\u00fcvenlik profili y\u00f6netilebilir d\u00fczeyde.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Pankreas kanseri genellikle sinsi ilerledi\u011fi i\u00e7in en tehlikeli kanser t\u00fcrlerinden biri olarak g\u00f6r\u00fcl\u00fcyor. Pankreas, midenin arkas\u0131nda derinde yer ald\u0131\u011f\u0131 i\u00e7in t\u00fcm\u00f6rler uzun s\u00fcre belirti vermeden b\u00fcy\u00fcyebiliyor. Kilo kayb\u0131, kar\u0131n a\u011fr\u0131s\u0131 ya da sar\u0131l\u0131k gibi belirtiler ortaya \u00e7\u0131kt\u0131\u011f\u0131nda ise hastal\u0131k \u00e7o\u011fu zaman yay\u0131lm\u0131\u015f oluyor.<\/p>\n\n\n\n

Bu da ameliyat gibi tedavilerin \u015fans\u0131n\u0131 ciddi bi\u00e7imde azalt\u0131yor. Bu geli\u015fmenin as\u0131l \u00f6nemi, pankreas kanserinde uzun s\u00fcredir s\u0131n\u0131rl\u0131 kalan tedavi se\u00e7eneklerine yeni bir yol a\u00e7ma ihtimali. Ara\u015ft\u0131rmac\u0131lar, elraglusibin yaln\u0131zca pankreas kanserinde de\u011fil, ba\u015fka t\u00fcm\u00f6r t\u00fcrlerinde de i\u015fe yaray\u0131p yaramayaca\u011f\u0131n\u0131 ileride ara\u015ft\u0131rmak istiyor.<\/p>\n\n\n\n

Yeni bir tedavi se\u00e7ene\u011finin do\u011fu\u015fu<\/strong><\/h2>\n\n\n\n

Faz 3 denemeleri ba\u015far\u0131l\u0131 olursa, bu ila\u00e7 pankreas kanseri tedavisinde standart yakla\u015f\u0131ma eklenen \u00f6nemli bir se\u00e7enek haline gelebilir. Ancak burada beklentiyi do\u011fru kurmak gerekiyor. Bu ila\u00e7 bug\u00fcn i\u00e7in kesin \u00e7\u00f6z\u00fcm ya da mucize tedavi olarak sunulmuyor. Yine de pankreas kanseri gibi seyri a\u011f\u0131r bir hastal\u0131kta hem 1 y\u0131ll\u0131k ya\u015fam oran\u0131n\u0131 ikiye katlamas\u0131 hem de \u00f6l\u00fcm riskini belirgin bi\u00e7imde azaltmas\u0131, uzmanlar\u0131n neden bu kadar dikkat kesildi\u011fini a\u00e7\u0131k\u00e7a g\u00f6steriyor.<\/p>\n\n\n\n

Kaynak:https:\/\/www.hurriyet.com.tr\/aile\/galeri-pankreas-kanserinde-umut-veren-gelisme-yeni-ilac-yasam-suresini-uzatti-43151891\/10<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

20.04.2026 20:30 ABD\u2019de geli\u015ftirilen yeni bir ila\u00e7, pankreas kanseri tedavisinde dikkat \u00e7ekici sonu\u00e7lar verdi. Elraglusib adl\u0131 deneysel ilac\u0131n kemoterapiyle birlikte kullan\u0131lmas\u0131, ileri evre pankreas kanseri hastalar\u0131nda hem ya\u015fam s\u00fcresini uzatt\u0131 hem de \u00f6l\u00fcm riskini belirgin bi\u00e7imde d\u00fc\u015f\u00fcrd\u00fc. Uzmanlara g\u00f6re bu sonu\u00e7lar, tedavisi en zor kanser t\u00fcrlerinden birinde yeni bir umut kap\u0131s\u0131 aralayabilir. ABD\u2019de geli\u015ftirilen yeni…<\/p>\n","protected":false},"author":5,"featured_media":6813,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[12],"tags":[2111],"class_list":["post-6778","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik","tag-pankreas"],"jetpack_featured_media_url":"https:\/\/dbsnewsmedia.com\/wp-content\/uploads\/2026\/04\/31-2.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/dbsnewsmedia.com\/index.php?rest_route=\/wp\/v2\/posts\/6778","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dbsnewsmedia.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dbsnewsmedia.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dbsnewsmedia.com\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/dbsnewsmedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6778"}],"version-history":[{"count":1,"href":"https:\/\/dbsnewsmedia.com\/index.php?rest_route=\/wp\/v2\/posts\/6778\/revisions"}],"predecessor-version":[{"id":6816,"href":"https:\/\/dbsnewsmedia.com\/index.php?rest_route=\/wp\/v2\/posts\/6778\/revisions\/6816"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dbsnewsmedia.com\/index.php?rest_route=\/wp\/v2\/media\/6813"}],"wp:attachment":[{"href":"https:\/\/dbsnewsmedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6778"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dbsnewsmedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6778"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dbsnewsmedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6778"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}